Because KRAS mutations are a recurrent finding in AOTs, Coura et al. [22], suggested the presence of KRAS G12V/R to help in the diagnosis of controversial cases of AOT, in the same way that BRAF V600E could be used in routine ameloblastoma diagnostics [14, 38]. This evidence concerns the gene BRAF and ameloblastoma.